FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103768660> ?p ?o ?g. }

• W2103768660 endingPage "870" @default.
• W2103768660 startingPage "861" @default.
• W2103768660 abstract "Recent advances in the design of MRI contrast agents have rendered the lanthanide complexes of DOTA-tetraamide ligands of considerable interest, both as responsive MR agents and paramagnetic chemical exchange saturation transfer agents. The potential utility of these complexes for in vivo applications is contingent upon them being well tolerated by the body. The purpose of this study was to examine how the nature of the amide substituent, and in particular its charge, affected the fate of these chelates postinjection.Complexes of 6 DOTA-tetraamide ligands were prepared in which the nature of the amide substituent was systematically altered. The 6 ligands formed 3 series: a phosphonate series that included tri-cationic, mono-anionic, and poly-anionic complexes; a carboxylate series made up of a tri-cationic complex and a mono-anionic complex; and lastly, a tri-cationic complex with an aromatic amide substituent. These complexes were labeled with an appropriate radioisotope, either Gd or Lu, and the biodistribution profiles in rats recorded 2 hours postinjection.Biodistribution profiles were initially acquired at low doses to minimize adverse effects. All the complexes studied were found to be excreted primarily through the renal system, with the majority of the dose being found in the urine. None of the complexes exhibited substantial uptake by bone, liver, and spleen, except for a complex with 4 phosphonate groups that exhibited significant bone targeting capabilities. Increasing the dose of each complex to that of a typical MR contrast agent was found to render all 3 tri-cationic complexes studied here acutely toxic. In contrast, no ill effects were observed after administration of similar doses of the corresponding anionic complexes.The absence of uptake by the liver and spleen indicate that irrespective of the ligand structure and charge, these complexes are not prone to dissociation in vivo. This is in agreement with previously published work that indicates high kinetic inertness for this class of compounds. At low doses, all complexes were well tolerated; however, for applications that require higher doses, the structure and charge of the ligand becomes a fundamentally important parameter. The results reported herein demonstrate the importance of incorporating negatively charged groups on amide substituents if a DOTA-tetraamide complex is to be employed at high doses in vivo." @default.
• W2103768660 created "2016-06-24" @default.
• W2103768660 creator A5005068927 @default.
• W2103768660 creator A5015130006 @default.
• W2103768660 creator A5018353132 @default.
• W2103768660 creator A5018561787 @default.
• W2103768660 creator A5022556494 @default.
• W2103768660 creator A5039095005 @default.
• W2103768660 creator A5047294961 @default.
• W2103768660 creator A5051025099 @default.
• W2103768660 creator A5072044740 @default.
• W2103768660 creator A5072119787 @default.
• W2103768660 creator A5073824046 @default.
• W2103768660 creator A5076971434 @default.
• W2103768660 creator A5083829548 @default.
• W2103768660 creator A5086666698 @default.
• W2103768660 date "2008-12-01" @default.
• W2103768660 modified "2023-10-10" @default.
• W2103768660 title "The Effect of the Amide Substituent on the Biodistribution and Tolerance of Lanthanide(III) DOTA-Tetraamide Derivatives" @default.
• W2103768660 cites W1966695044 @default.
• W2103768660 cites W1968280695 @default.
• W2103768660 cites W1972891920 @default.
• W2103768660 cites W1976831499 @default.
• W2103768660 cites W1979819945 @default.
• W2103768660 cites W1983510481 @default.
• W2103768660 cites W1988256833 @default.
• W2103768660 cites W1992710364 @default.
• W2103768660 cites W2001362752 @default.
• W2103768660 cites W2009683684 @default.
• W2103768660 cites W2016280328 @default.
• W2103768660 cites W2024924445 @default.
• W2103768660 cites W2028945745 @default.
• W2103768660 cites W2029401868 @default.
• W2103768660 cites W2033503179 @default.
• W2103768660 cites W2035562743 @default.
• W2103768660 cites W2036405145 @default.
• W2103768660 cites W2046861300 @default.
• W2103768660 cites W2053691477 @default.
• W2103768660 cites W2056902212 @default.
• W2103768660 cites W2062374379 @default.
• W2103768660 cites W2063867592 @default.
• W2103768660 cites W2064294421 @default.
• W2103768660 cites W2066393913 @default.
• W2103768660 cites W2070864421 @default.
• W2103768660 cites W2075078796 @default.
• W2103768660 cites W2082774686 @default.
• W2103768660 cites W2083559139 @default.
• W2103768660 cites W2085722234 @default.
• W2103768660 cites W2090437724 @default.
• W2103768660 cites W2092054651 @default.
• W2103768660 cites W2109983572 @default.
• W2103768660 cites W2117349353 @default.
• W2103768660 cites W2121107057 @default.
• W2103768660 cites W2122300677 @default.
• W2103768660 cites W2127194007 @default.
• W2103768660 cites W2130291666 @default.
• W2103768660 cites W2159412453 @default.
• W2103768660 cites W2317642741 @default.
• W2103768660 cites W3005029028 @default.
• W2103768660 cites W4234577026 @default.
• W2103768660 doi "https://doi.org/10.1097/rli.0b013e318186531d" @default.
• W2103768660 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2696888" @default.
• W2103768660 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19002058" @default.
• W2103768660 hasPublicationYear "2008" @default.
• W2103768660 type Work @default.
• W2103768660 sameAs 2103768660 @default.
• W2103768660 citedByCount "24" @default.
• W2103768660 countsByYear W21037686602012 @default.
• W2103768660 countsByYear W21037686602013 @default.
• W2103768660 countsByYear W21037686602015 @default.
• W2103768660 countsByYear W21037686602017 @default.
• W2103768660 countsByYear W21037686602018 @default.
• W2103768660 countsByYear W21037686602020 @default.
• W2103768660 countsByYear W21037686602022 @default.
• W2103768660 crossrefType "journal-article" @default.
• W2103768660 hasAuthorship W2103768660A5005068927 @default.
• W2103768660 hasAuthorship W2103768660A5015130006 @default.
• W2103768660 hasAuthorship W2103768660A5018353132 @default.
• W2103768660 hasAuthorship W2103768660A5018561787 @default.
• W2103768660 hasAuthorship W2103768660A5022556494 @default.
• W2103768660 hasAuthorship W2103768660A5039095005 @default.
• W2103768660 hasAuthorship W2103768660A5047294961 @default.
• W2103768660 hasAuthorship W2103768660A5051025099 @default.
• W2103768660 hasAuthorship W2103768660A5072044740 @default.
• W2103768660 hasAuthorship W2103768660A5072119787 @default.
• W2103768660 hasAuthorship W2103768660A5073824046 @default.
• W2103768660 hasAuthorship W2103768660A5076971434 @default.
• W2103768660 hasAuthorship W2103768660A5083829548 @default.
• W2103768660 hasAuthorship W2103768660A5086666698 @default.
• W2103768660 hasBestOaLocation W21037686602 @default.
• W2103768660 hasConcept C145148216 @default.
• W2103768660 hasConcept C178790620 @default.
• W2103768660 hasConcept C183882617 @default.
• W2103768660 hasConcept C185592680 @default.
• W2103768660 hasConcept C197404232 @default.
• W2103768660 hasConcept C201399114 @default.
• W2103768660 hasConcept C201770740 @default.
• W2103768660 hasConcept C202751555 @default.

• next